Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 2d ago.
| Ticker | Firm | Action | Rating | Target | Date |
|---|---|---|---|---|---|
| ARWRArrowhead Pharmaceuticals, Inc. | Chardan Capital | Maintained | Buy | $115 | Oct 15 |
| GOSSGossamer Bio, Inc. | Chardan Capital | Maintained | Buy | $160 | Oct 15 |
| GOSSGossamer Bio, Inc. | Chardan Capital | Initiated |
Showing the 4 most recent actions.
| $160 |
| Oct 13 |
| DYNDyne Therapeutics, Inc. | Chardan Capital | Maintained | Buy | $38 | Sep 30 |